Filtered By:
Specialty: Cardiology
Condition: Cardiogenic Shock

This page shows you your search results in order of date. This is page number 10.

Order by Relevance | Date

Total 235 results found since Jan 2013.

Optimal timing of coronary artery bypass grafting in hemodynamically stable patients after myocardial infarction and definition of poor prognostic factors
ConclusionOptimal timing for surgical revascularization of MI seems to be between 3 and 10 days in stable patients. But, timing is not the only influencing factors in death rate, patient's health condition and disease severity must be considered in the individual management strategy.
Source: Archives of Cardiovascular Diseases Supplements - January 7, 2020 Category: Cardiology Source Type: research

Initiation of Extracorporeal Membrane Oxygenation in the Cardiac Catheterization Laboratory: The Mayo Clinic Experience.
CONCLUSIONS: ECMO should be considered early during the resuscitation attempts of selected patients with ongoing cardiopulmonary resuscitation or refractory cardiogenic shock in the cardiac catheterization laboratory. PMID: 31841997 [PubMed - as supplied by publisher]
Source: The Journal of Invasive Cardiology - December 18, 2019 Category: Cardiology Tags: J Invasive Cardiol Source Type: research

In ‐hospital ventricular arrhythmia in heart failure patients: 7 year follow‐up of the multi‐centric HEARTS registry
ConclusionsLower mean age of VA complicated HF patients is a matter of concern in the Saudi population. HF associated with VA increased in ‐hospital events and all‐cause mortality indicating poor prognosis and survival. These findings enable risk stratification and reflect on the importance of early recognition of the clinical markers and predictors of VA prompting immediate management.
Source: ESC Heart Failure - November 20, 2019 Category: Cardiology Authors: Basel Alenazy, Shabana Tharkar, Tarek Kashour, Khalid Faiz Alhabib, Hussam Alfaleh, Ahmad Hersi Tags: Original Research Article Source Type: research

Non-Invasive Cardiac Output Monitoring in Cardiogenic Shock: The NICOM Study
The bioreactance technique is a relatively new, totally noninvasive technique that is used to measure cardiac output (CO) and is easy to use. The Non-Invasive Cardiac Output Monitor (NICOM) is 1 such system. Although approved by the Food and Drug Administration for measurement of stroke volume, there is a paucity of literature validating this technology in decompensated heart failure and cardiogenic shock.
Source: Journal of Cardiac Failure - November 17, 2019 Category: Cardiology Authors: Aniket S. Rali, Tyler Buechler, Bridget Van Gotten, Andrew Waters, Zubair Shah, Nicholas Haglund, Andrew Sauer Tags: Brief Report Source Type: research

Non-Invasive Cardiac Output Monitoring in Cardiogenic Shock – The NICOMTM Study
The bioreactance technique is a relatively new, totally non-invasive technique used to measure cardiac output that is easy to use. Non Invasive Cardiac Output Monitor (NICOM) is one such system (Cheetah Medical Inc). Although approved by FDA for measurement of stroke volume, there is a paucity of literature validating this technology in decompensated heart failure and cardiogenic shock (CS).
Source: Journal of Cardiac Failure - November 17, 2019 Category: Cardiology Authors: Aniket S. Rali, Tyler Buechler, Bridget Van Gotten, Andrew Waters, Zubair Shah, Nicholas Haglund, Andrew Sauer Tags: Brief Report Source Type: research

Comparative Outcomes of Transapical Versus Transfemoral Access for Transcatheter Aortic Valve Replacement in Diabetics
ConclusionsThis observational analysis showed no difference in-hospital mortality between TF-TAVR and TA-TAVR among diabetic patients. Studies exploring the optimal access for TAVR among diabetics are recommended.
Source: Cardiology and Therapy - November 10, 2019 Category: Cardiology Source Type: research

Systematic Review and Meta-Analysis of Interventional Emergency Treatment of Decompensated Severe Aortic Stenosis.
CONCLUSION: Mortality in CS patients due to decompensated severe AS is high, regardless of interventional treatment strategy. Both eBAV and eTAVR seem feasible. As eTAVR is associated with better initial improvements in hemodynamics and simultaneously avoids sequential interventions, it might be favorable to eBAV in select patients. If eTAVR is not available, eBAV might serve as a "bridge" to elective TAVR. PMID: 31611428 [PubMed - as supplied by publisher]
Source: The Journal of Invasive Cardiology - October 16, 2019 Category: Cardiology Tags: J Invasive Cardiol Source Type: research

Outcomes Among Clopidogrel, Prasugrel, and Ticagrelor in ST-Elevation Myocardial Infarction Patients Who Underwent Primary Percutaneous Coronary Intervention From the TOTAL Trial
ConclusionsIn this observational analysis of STEMI patients who underwent primary percutaneous coronary intervention, ticagrelor was associated with improved outcomes compared with clopidogrel and prasugrel. An appropriately powered randomized trial is needed to confirm these findings.RésuméContexteIl n’existe pas d’analyse robuste comparant les inhibiteurs P2Y12 à prise orale (clopidogrel, prasugrel et ticagrélor) chez les patients ayant subi un infarctus du myocarde avec élévation du segment ST (STEMI) traités par une intervention coronaire percutanée (ICP) primaire. Nous avons entrepris d’évaluer les rés...
Source: Canadian Journal of Cardiology - October 9, 2019 Category: Cardiology Source Type: research

Obesity Paradox in TAVR: Nationwide Study from 2011-14 Comparing Outcomes of Patients with versus without Obesity Undergoing TAVR
Obesity is associated with several cardiovascular diseases including aortic valve stenosis. Studies have demonstrated a beneficial effect of obesity on patients with cardiovascular disease, deemed the “obesity paradox.” This paradox is also present in obese patients undergoing total aortic valve replacement (TAVR) when examining both short and long-term mortality rates, although the data is conflicting. We aim to investigate the effects of obesity on mortality, length of hospital stay, and ra tes of stroke and cardiogenic shock in patients undergoing TAVR.
Source: Journal of Cardiac Failure - July 31, 2019 Category: Cardiology Authors: Hassaan B. Arshad, Aneil Bhalla, Sara Ayaz Butt, Rehan Umar, Umar Jamshed Sharif Khwaja, Hashim Jilani Tags: 385 Source Type: research

Initiation of ivabradine in cardiogenic shock
ConclusionsIn our small non ‐randomized series of patients in cardiogenic shock, ivabradine was safely used to reduce HR in patients previously intolerant of beta‐blockade. There are limited data surrounding the use of ivabradine in cardiogenic shock, and future studies should be undertaken to determine the optimal HR in h umans with cardiogenic shock and whether systematic limitation of peak HR may improve outcomes.
Source: ESC Heart Failure - July 22, 2019 Category: Cardiology Authors: Michael H. Chiu, Jonathan G. Howlett, Nakul C. Sharma Tags: Short Communication Source Type: research

Revascularization Strategies in Patients With STEMI: Culprit-Only vs Multivessel Revascularization Using Percutaneous Coronary Intervention.
CONCLUSIONS: The relative frequency of multivessel vs culprit-only PCI has not changed from 2009-2015. Index complete revascularization for STEMI-MVD patients is more likely to be performed in those with worse presentations and is associated with worse in-hospital complications. PMID: 31303602 [PubMed - as supplied by publisher]
Source: The Journal of Invasive Cardiology - July 17, 2019 Category: Cardiology Tags: J Invasive Cardiol Source Type: research

Outcomes Among Clopidogrel, Prasugrel, And Ticagrelor In Stemi Patients Undergoing Primary Percutaneous Coronary Intervention From The Total Trial
ConclusionsIn this observational analysis of STEMI patients undergoing PPCI, ticagrelor was associated with improved outcomes compared to clopidogrel and prasugrel. An appropriately powered randomized trial is needed to confirm these findings.
Source: Canadian Journal of Cardiology - May 8, 2019 Category: Cardiology Source Type: research

13 The shock team approach: the rationale and evidence
Cardiogenic shock (CS) is defined as a state of ineffective cardiac output caused by a cardiac disorder that results in both clinical and biochemical manifestations of inadequate tissue perfusion.1 Among patients presenting with CS, there is a spectrum of disease whereby some patients can be stabilised with pharmacologic interventions alone, while others require escalation to mechanical circulatory support (MCS).2 As patients and treatment options both become increasingly complex, comprehensive critical care may be best delivered in disease-specific service line ICUs.2 The model of the cardiac ICU has transitioned over tim...
Source: Heart Asia - April 24, 2019 Category: Cardiology Authors: Kiernan, M. S. Tags: Keynote Lecture Source Type: research

Twenty-Year Results of Surgical Pulmonary Thromboembolectomy in Acute Pulmonary Embolism.
CONCLUSION: Pulmonary embolectomy can be performed in high-risk patients with massive pulmonary embolism with acceptable clinical outcome and good long-term survival. PMID: 30919668 [PubMed - as supplied by publisher]
Source: Scandinavian Cardiovascular Journal - March 30, 2019 Category: Cardiology Tags: Scand Cardiovasc J Source Type: research

Mechanical circulatory support with Impella versus intra-aortic balloon pump or medical treatment in cardiogenic shock —a critical appraisal of current data
ConclusionIn patients suffering from severe CS due to AMI, the use of Impella is not associated with improved short-time survival but with higher complications rates compared to IABP and medical treatment. Better patient selection avoiding Impella implantation in futile situations or in possible lower risk CS might be necessary to elucidate possible advantages of Impella in future studies.
Source: Clinical Research in Cardiology - March 20, 2019 Category: Cardiology Source Type: research